BLOG
Can Semaglutide Reduce Alcohol Cravings? What the Research Shows
A 2025 randomized trial in JAMA Psychiatry found once-weekly semaglutide reduced alcohol consumption in adults with alcohol use disorder. What the study found, and the...
Tirzepatide: Revolutionizing Weight Loss with IVUSE
How tirzepatide works for weight loss, what the SURMOUNT-1 trial actually showed, and how compounded tirzepatide is prescribed and managed at IVUSE+ through licensed-clinician telehealth.
Beyond Blood Sugar: Additional Health Benefits of Tirzepatide and How IVUSE+ Helps You Optimize Treatment
Discover the dual benefits of Tirzepatide for diabetes and weight loss. Learn how IVSUE provides personalized guidance and resources to help optimize your treatment and...
Semaglutide: New Formulation for Easier Administration Approved
Discover the newly approved, easier-to-administer formulations of Semaglutide, including the innovative oral version and convenient long-acting injections. Learn how these advancements can improve adherence, patient...
Debunking Myths About Tirzepatide: Separating Fact from Fiction
Tirzepatide myths, debunked with evidence. Does it work overnight, is it a steroid, does it affect birth control, and will it cause constant nausea or...
Frequently Asked Questions About Semaglutide
Clear answers to the most common questions about semaglutide: how it works, typical dosing, contraindications, side effects, pregnancy, and cost.
The Ultimate Guide to Tirzepatide for Weight Loss
How tirzepatide works for weight loss: its dual GIP/GLP-1 mechanism, SURMOUNT-1 clinical trial results (~21% average body-weight reduction over 72 weeks), and how to start...
A New Dawn in Obesity Treatment: Semaglutide + IVUSE
IVUSE Atlanta integrates semaglutide with IV therapy, transforming the fight against obesity through personalized, holistic treatment solutions
